• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比卡鲁胺在单斜晶型多晶型物和雄激素受体结合口袋中的分子相互作用的电荷密度视图。

Charge density view on bicalutamide molecular interactions in the monoclinic polymorph and androgen receptor binding pocket.

作者信息

Korlyukov Alexander A, Malinska Maura, Vologzhanina Anna V, Goizman Mikhail S, Trzybinski Damian, Wozniak Krzysztof

机构信息

A. N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Vavilov St. 28, Moscow 119991, Russian Federation.

Biological and Chemical Research Centre, Department of Chemistry, University of Warsaw, Żwirki i Wigury 101, Warszawa 02089, Poland.

出版信息

IUCrJ. 2020 Jan 1;7(Pt 1):71-82. doi: 10.1107/S2052252519014416.

DOI:10.1107/S2052252519014416
PMID:31949906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6949590/
Abstract

High-resolution single-crystal X-ray measurements of the monoclinic polymorph of bicalutamide and the aspherical atom databank approach have served as a basis for a reconstruction of the charge density distribution of the drug and its androgen receptor (AR) and albumin complexes. The contributions of various types of intermolecular interactions to the total crystal energy or ligand:AR energy were estimated. The cyan and amide groups secured the ligand placement in the albumin (Lys-137) and the AR binding pocket (Leu-704, Asn-705, Arg-752), and also determined the packing of the small-molecule crystals. The total electrostatic interaction energy on average was -230 kJ mol, comparable with the electrostatic lattice energy of the monoclinic bicalutamide polymorph. This is the result of similar distributions of electropositive and electronegative regions on the experimental and theoretical molecular electrostatic potential maps despite differences in molecular conformations. In general, bicalutamide interacted with the studied proteins with similar electrostatic interaction energies and adjusted its conformation and electrostatic potential to fit the binding pocket in such a way as to enhance the interactions, hydrogen bonds and π⋯π stacking.

摘要

比卡鲁胺单斜晶型的高分辨率单晶X射线测量以及非球面原子数据库方法,为重建该药物及其雄激素受体(AR)和白蛋白复合物的电荷密度分布奠定了基础。估算了各种类型分子间相互作用对总晶体能量或配体:AR能量的贡献。氰基和酰胺基团确保了配体在白蛋白(Lys-137)和AR结合口袋(Leu-704、Asn-705、Arg-752)中的位置,同时也决定了小分子晶体的堆积方式。平均总静电相互作用能为-230 kJ mol,与单斜比卡鲁胺多晶型的静电晶格能相当。这是由于尽管分子构象存在差异,但实验和理论分子静电势图上正电和负电区域的分布相似。总体而言,比卡鲁胺与所研究蛋白质的静电相互作用能相似,并调整其构象和静电势以适应结合口袋,从而增强相互作用、氢键和π⋯π堆积。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/db37142f4bfc/m-07-00071-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/4cdb27bb7402/m-07-00071-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/64730d0b34f9/m-07-00071-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/6ba0fc33e7e6/m-07-00071-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/6a74bd7c40d9/m-07-00071-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/2b899dcb4472/m-07-00071-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/90b491a2bf09/m-07-00071-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/defa1e249319/m-07-00071-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/2d409d5c5b48/m-07-00071-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/ea89e3a63958/m-07-00071-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/db37142f4bfc/m-07-00071-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/4cdb27bb7402/m-07-00071-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/64730d0b34f9/m-07-00071-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/6ba0fc33e7e6/m-07-00071-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/6a74bd7c40d9/m-07-00071-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/2b899dcb4472/m-07-00071-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/90b491a2bf09/m-07-00071-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/defa1e249319/m-07-00071-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/2d409d5c5b48/m-07-00071-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/ea89e3a63958/m-07-00071-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d54c/6949590/db37142f4bfc/m-07-00071-fig10.jpg

相似文献

1
Charge density view on bicalutamide molecular interactions in the monoclinic polymorph and androgen receptor binding pocket.比卡鲁胺在单斜晶型多晶型物和雄激素受体结合口袋中的分子相互作用的电荷密度视图。
IUCrJ. 2020 Jan 1;7(Pt 1):71-82. doi: 10.1107/S2052252519014416.
2
Sunitinib: from charge-density studies to interaction with proteins.舒尼替尼:从电荷密度研究到与蛋白质的相互作用
Acta Crystallogr D Biol Crystallogr. 2014 May;70(Pt 5):1257-70. doi: 10.1107/S1399004714002351. Epub 2014 Apr 29.
3
Tetrel Bonding and Other Non-Covalent Interactions Assisted Supramolecular Aggregation in a New Pb(II) Complex of an Isonicotinohydrazide.四配位键和其他非共价相互作用辅助新型异烟酰肼铅(II)配合物的超分子聚集
Molecules. 2020 Sep 4;25(18):4056. doi: 10.3390/molecules25184056.
4
Ligand-Receptor Interactions of : A View from Charge Density Study and QM/MM Calculations.配体-受体相互作用:电荷密度研究与量子力学/分子力学计算视角
Biomedicines. 2023 Mar 1;11(3):743. doi: 10.3390/biomedicines11030743.
5
Progress in the understanding of drug-receptor interactions, part 2: experimental and theoretical electrostatic moments and interaction energies of an angiotensin II receptor antagonist (C30H30N6(O)3S).药物 - 受体相互作用理解的进展,第2部分:血管紧张素II受体拮抗剂(C30H30N6(O)3S)的实验和理论静电矩及相互作用能
Chemistry. 2007;13(24):6942-56. doi: 10.1002/chem.200601516.
6
Fast analytical evaluation of intermolecular electrostatic interaction energies using the pseudoatom representation of the electron density. III. Application to crystal structures via the Ewald and direct summation methods.使用电子密度的伪原子表示法对分子间静电相互作用能进行快速分析评估。III. 通过埃瓦尔德方法和直接求和法应用于晶体结构
Acta Crystallogr A Found Adv. 2020 Nov 1;76(Pt 6):630-651. doi: 10.1107/S2053273320009584. Epub 2020 Sep 18.
7
Structural Changes Due to Antagonist Binding in Ligand Binding Pocket of Androgen Receptor Elucidated Through Molecular Dynamics Simulations.通过分子动力学模拟阐明雄激素受体配体结合口袋中拮抗剂结合引起的结构变化。
Front Pharmacol. 2018 May 15;9:492. doi: 10.3389/fphar.2018.00492. eCollection 2018.
8
Structural and computational analysis of intermolecular interactions in a new 2-thiouracil polymorph.一种新型2-硫尿嘧啶多晶型物分子间相互作用的结构与计算分析
Acta Crystallogr C Struct Chem. 2017 Dec 1;73(Pt 12):1078-1086. doi: 10.1107/S205322961701542X. Epub 2017 Nov 9.
9
Intermolecular interactions, charge-density distribution and the electrostatic properties of pyrazinamide anti-TB drug molecule: an experimental and theoretical charge-density study.吡嗪酰胺抗结核药物分子的分子间相互作用、电荷密度分布及静电性质:一项实验与理论电荷密度研究
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2014 Jun;70(Pt 3):568-79. doi: 10.1107/S205252061303388X. Epub 2014 May 24.
10
On the interplay between CH...O and OH...O interactions in determining crystal packing and molecular conformation: an experimental and theoretical charge density study of the fungal secondary metabolite austdiol (C12H12O5).关于CH...O和OH...O相互作用在决定晶体堆积和分子构象中的相互作用:真菌次生代谢产物奥斯特二醇(C12H12O5)的实验和理论电荷密度研究
J Phys Chem B. 2006 Mar 30;110(12):6405-14. doi: 10.1021/jp056823y.

引用本文的文献

1
A SARM a Day Keeps the Weakness Away: A Computational Approach for Selective Androgen Receptor Modulators (SARMs) and Their Interactions with Androgen Receptor and 5‑Alpha Reductase Proteins.每天一片选择性雄激素受体调节剂,远离虚弱:一种针对选择性雄激素受体调节剂(SARMs)及其与雄激素受体和5-α还原酶蛋白相互作用的计算方法。
ACS Omega. 2025 Jul 18;10(29):31649-31667. doi: 10.1021/acsomega.5c02504. eCollection 2025 Jul 29.
2
Ligand-Receptor Interactions of : A View from Charge Density Study and QM/MM Calculations.配体-受体相互作用:电荷密度研究与量子力学/分子力学计算视角
Biomedicines. 2023 Mar 1;11(3):743. doi: 10.3390/biomedicines11030743.
3

本文引用的文献

1
model energies and energy frameworks: extension to metal coordination compounds, organic salts, solvates and open-shell systems.模型能量与能量框架:扩展至金属配位化合物、有机盐、溶剂化物及开壳层体系
IUCrJ. 2017 Jul 4;4(Pt 5):575-587. doi: 10.1107/S205225251700848X. eCollection 2017 Sep 1.
2
Molecular mechanism of R-bicalutamide switching from androgen receptor antagonist to agonist induced by amino acid mutations using molecular dynamics simulations and free energy calculation.利用分子动力学模拟和自由能计算研究氨基酸突变诱导R-比卡鲁胺从雄激素受体拮抗剂转变为激动剂的分子机制。
J Comput Aided Mol Des. 2016 Dec;30(12):1189-1200. doi: 10.1007/s10822-016-9992-2. Epub 2016 Nov 15.
3
Novel Polymorph of Favipiravir-An Antiviral Medication.
法匹拉韦的新型多晶型物——一种抗病毒药物。
Pharmaceutics. 2021 Jan 21;13(2):139. doi: 10.3390/pharmaceutics13020139.
4
Intermolecular Interactions in Crystal Structures of Imatinib-Containing Compounds.含伊马替尼化合物晶体结构中的分子间相互作用。
Int J Mol Sci. 2020 Nov 26;21(23):8970. doi: 10.3390/ijms21238970.
Charge Density and Electrostatic Potential Study of 16α,17β-Estriol and the Binding of Estrogen Molecules to the Estrogen Receptors ERα and ERβ.
16α,17β-雌三醇的电荷密度与静电势研究以及雌激素分子与雌激素受体ERα和ERβ的结合
J Phys Chem B. 2016 Sep 1;120(34):8882-91. doi: 10.1021/acs.jpcb.6b05961. Epub 2016 Aug 18.
4
Promising Tools in Prostate Cancer Research: Selective Non-Steroidal Cytochrome P450 17A1 Inhibitors.在前列腺癌研究中具有应用前景的工具:选择性非甾体细胞色素 P45017A1 抑制剂。
Sci Rep. 2016 Jul 12;6:29468. doi: 10.1038/srep29468.
5
Predicted structures of new Vitamin D Receptor agonists based on available X-ray structures.基于现有X射线结构预测的新型维生素D受体激动剂的结构
Steroids. 2015 Dec;104:220-9. doi: 10.1016/j.steroids.2015.10.007. Epub 2015 Oct 22.
6
Contributions of charge-density research to medicinal chemistry.电荷密度研究对药物化学的贡献。
IUCrJ. 2014 Sep 23;1(Pt 6):457-69. doi: 10.1107/S2052252514018867. eCollection 2014 Nov 1.
7
More about systematic errors in charge-density studies.电荷密度研究中系统误差的更多内容。
Acta Crystallogr A Found Adv. 2014 Sep;70(Pt 5):499-513. doi: 10.1107/S2053273314012984. Epub 2014 Aug 30.
8
Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis.通过肽筛选和 X 射线结构分析鉴定一种新的雄激素受体(AR)共调节剂 BUD31 和相关肽,以抑制野生型和突变型 AR 介导的前列腺癌生长。
Mol Oncol. 2014 Dec;8(8):1575-87. doi: 10.1016/j.molonc.2014.06.009. Epub 2014 Jun 24.
9
Sunitinib: from charge-density studies to interaction with proteins.舒尼替尼:从电荷密度研究到与蛋白质的相互作用
Acta Crystallogr D Biol Crystallogr. 2014 May;70(Pt 5):1257-70. doi: 10.1107/S1399004714002351. Epub 2014 Apr 29.
10
Structural studies of several clinically important oncology drugs in complex with human serum albumin.几种临床上重要的肿瘤药物与人类血清白蛋白复合物的结构研究。
Biochim Biophys Acta. 2013 Dec;1830(12):5356-74. doi: 10.1016/j.bbagen.2013.06.032. Epub 2013 Jul 6.